Frisch Steven J.

Chief Strategy Officer Frisch sells 6,048 shares at avg $123.99 for $749.9K on 2024-08-16

Steven J. Frisch, Chief Strategy Officer at PLEXUS CORP, executed two separate sales totaling 6,048 shares (6.0K shares) for $749,896.20 ($749.9K) on 2024-08-16, reducing his holdings from 36,118 shares to 30,070 shares (-16.7% vs pre-transaction holdings). The sales occurred at an average price of $123.99, near the stock's current price of $122.54 and within proximity of the 52-week high of $129.85. Frisch's cross-ticker track record shows his prior 14 open-market sells produced an average 90-day return of +9.3%, indicating his past sales have typically preceded stock appreciation rather than declines, with a 90d well-timed rate of 0.00%. At PLEXUS specifically, his 5 most recent trades (all sales on 2024-07-30 and 2024-07-31) are too recent to assess outcomes. The company's fundamentals show revenue of $990,967,000.00 ($991.0M) with net income of $25,140,000.00 ($25.1M) and a P/E of 30.11, placing the stock at a meaningful valuation multiple relative to current earnings.

Chief Strategy Officer Steven J. Frisch sold 13,190 shares of PLXS for $1,672,150.35 across 6 transactions on 2024-07-30/31

Steven J. Frisch, Chief Strategy Officer of PLEXUS CORP, executed 6 separate sales totaling 13,190 shares for $1,672,150.35 at prices ranging from $124.95 to $129.50 across July 30–31, 2024, representing a -26.8% reduction in his 49,308-share position. The blended average price of $126.77 sits 1.8% above the current price of $124.53 and within 2.5% of the 52-week high of $129.85, suggesting the sales occurred near a local peak. His prior 5 trades at PLXS (all sells in May 2024) showed negative 30-day returns (-1.4% to -3.8%), and across his broader cross-ticker sell history, the 90-day well-timed rate is 0.00%, indicating a pattern of selling ahead of continued weakness rather than strength. The company shows solid fundamentals with $997.5M quarterly revenue and +10.0% annual growth, though the P/E of 33.57 reflects a premium valuation; the recent +19.8% 30-day appreciation may have created the window for these sales.